Fujisawa H, Ito H, Kashiwagi S, Nomura S, Toyosawa M
Department of Neurosurgery, Yamaguchi University School of Medicine, Ube, Japan.
J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):388-94. doi: 10.1136/jnnp.59.4.388.
The kallikrein-kinin system is closely related to both fibrinolysis and coagulation, and bradykinin--the end product of this system--is a powerful mediator which increases vascular permeability. In the present study, to test the hypothesis that the kallikrein-kinin system plays a part in the aetiology of chronic subdural haematomas, components of this system (prekallikrein, high molecular weight kininogen (HMW-kininogen), and bradykinin), and those of the fibrinolytic and coagulation systems were measured at 134 haematoma sites in 119 patients. The activities of prekallikrein and HMW-kininogen in the haematomas were significantly lower than those in the plasma of the patients, and showed a parallel decrease. The bradykinin concentration in the haematomas was significantly higher than that in the plasma. These results indicate activation of the kallikrein-kinin system in chronic subdural haematomas. The activation of both fibrinolysis and coagulation was also shown, and there was a significant correlation between HMW-kininogen and plasminogen, fibrin/fibrinogen degradation products, or platelets in the haematomas. This suggests regulation of fibrinolysis and coagulation by the kallikrein-kinin system or mutual stimulation of these systems. In the outer membrane, perivascular haemorrhage, interstitial oedema, and leucocyte migration were evident microscopically, indicating an increase in vascular permeability. The protein concentration in the haematomas was significantly higher than that in the peripheral blood, indicating plasma exudation from the capillaries in the outer membrane. The activation of the kallikrein-kinin system, by increasing vascular permeability, may cause blood extravasation and plasma exudation from the capillaries into both the outer membrane and the haematoma cavity, resulting in enlargement of the haematoma.
激肽释放酶 - 激肽系统与纤维蛋白溶解和凝血密切相关,而该系统的终产物缓激肽是一种强大的介质,可增加血管通透性。在本研究中,为了验证激肽释放酶 - 激肽系统在慢性硬膜下血肿病因中起作用这一假设,对119例患者的134个血肿部位的该系统成分(前激肽释放酶、高分子量激肽原(HMW - 激肽原)和缓激肽)以及纤维蛋白溶解和凝血系统成分进行了测量。血肿中前激肽释放酶和HMW - 激肽原的活性显著低于患者血浆中的活性,且呈平行下降。血肿中缓激肽浓度显著高于血浆中的浓度。这些结果表明慢性硬膜下血肿中激肽释放酶 - 激肽系统被激活。同时也显示出纤维蛋白溶解和凝血均被激活,并且血肿中HMW - 激肽原与纤溶酶原、纤维蛋白/纤维蛋白原降解产物或血小板之间存在显著相关性。这表明激肽释放酶 - 激肽系统对纤维蛋白溶解和凝血有调节作用或这些系统之间相互刺激。在外膜中,显微镜下可见血管周围出血、间质水肿和白细胞迁移,表明血管通透性增加。血肿中的蛋白质浓度显著高于外周血中的蛋白质浓度,表明外膜中的毛细血管有血浆渗出。激肽释放酶 - 激肽系统的激活通过增加血管通透性,可能导致血液外渗和血浆从毛细血管渗入外膜和血肿腔,从而导致血肿扩大。